ScripFor the first time in a while, Viking Therapeutics is sailing choppy seas despite a Phase II readout showing that oral GLP-1/GIP receptor agonist VK2735 hit its marks on a primary endpoint of mean wei
Pink SheetRecent anti-kickback legislation brought against Eli Lilly by the state of Texas and relator Health Choice Alliance suggests the company’s direct-to-consumer web portal is aligned with company program
ScripLeo Pharma has upped its guidance for full-year 2025 after posting a healthy set of financials for the first half of the year, thanks to a strong showing in the US for its atopic dermatitis drug Adbry
ScripThe direct-to-patient (DTP) distribution model is expected to gain traction as US President Donald Trump presses for most favored nation (MFN) pricing, but the approach, experts underline, comes with